Australia is piloting a $4 million digital portal for rare cancers, funded by the federal government. The Australian Rare Cancer Portal, managed by BioGrid Australia, offers expert opinions, evidence-based information, and access to clinical trials. Meanwhile, New Zealand has allocated $2.8 million for healthcare AI research, and Northeast Health Wangaratta upgraded its EMR system with Orion Health’s solution for improved access to information.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
